With recent advances in molecular diagnostics that allow prenatal diagnosis, helping to identify female carriers before their first births, carrier mothers can be prevented from giving birth to offspring with DMD/BMD, consequently affecting the distribution of DMD/BMD pathogenic variants. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.